Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition By Robinson - Test Bank

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition By Robinson – Test Bank

$15.00

Pay And Download 

Complete Test Bank With Answers

 

 

Sample Questions Posted Below

 

Chapter 5. Adverse Drug Reactions

Multiple Choice

Identify the choice that best completes the statement or answers the question.

____ 1. Which of the following patients would be at higher risk of experiencing adverse drug reactions (ADRs):

1. A 32-year-old male
2. A 22-year-old female
3. A 3-month-old female
4. A 48-year-old male

____ 2. Infants and young children are at higher risk of ADRs due to:

1. Immature renal function in school-age children
2. Lack of safety and efficacy studies in the pediatric population
3. Children’s skin being thicker than adults, requiring higher dosages of topical medication
4. Infant boys having a higher proportion of muscle mass, leading to a higher volume of distribution

____ 3. The elderly are at high risk of ADRs due to:

1. Having greater muscle mass than younger adults, leading to higher volume of distribution
2. The extensive studies that have been conducted on drug safety in this age group
3. The blood-brain barrier being less permeable, requiring higher doses to achieve therapeutic effect
4. Age-related decrease in renal function

____ 4. The type of adverse drug reaction that is idiosyncratic when a drug given in the usual therapeutic doses is type:

1. A
2. B
3. C
4. D

____ 5. Digoxin may cause a type A adverse drug reaction due to:

1. Idiosyncratic effects
2. Its narrow therapeutic index
3. Being a teratogen
4. Being a carcinogen

____ 6. Sarah developed a rash after using a topical medication. This is a type __ allergic drug reaction.

1. I
2. II
3. III
4. IV

____ 7. A patient may develop neutropenia from using topical Silvadene for burns. Neutropenia is a(n):

1. Cytotoxic hypersensitivity reaction
2. Immune complex hypersensitivity
3. Immediate hypersensitivity reaction
4. Delayed hypersensitivity reaction

____ 8. Anaphylactic shock is a:

1. Type I reaction, called immediate hypersensitivity reaction
2. Type II reaction, called cytotoxic hypersensitivity reaction
3. Type III allergic reaction, called immune complex hypersensitivity
4. Type IV allergic reaction, called delayed hypersensitivity reaction

____ 9. James has hypothalamic-pituitary-adrenal axis suppression from chronic prednisone (a corticosteroid) use. He is at risk for what type of adverse drug reaction?

1. Type B
2. Type C
3. Type E
4. Type F

____ 10. Immunomodulators such as azathioprine may cause a delayed adverse drug reaction known as a type D reaction because they are known:

1. Teratogens
2. Carcinogens
3. To cause hypersensitivity reactions
4. Hypothalamus-pituitary-adrenal axis suppressants

____ 11. A 24-year-old male received multiple fractures in a motor vehicle accident that required significant amounts of opioid medication to treat his pain. He is at risk for a _____ adverse drug reaction when he no longer requires the opioids.

1. Rapid
2. First-dose
3. Late
4. Delayed

____ 12. An example of a first-dose reaction that may occur includes:

1. Orthostatic hypotension that does not occur with repeated doses
2. Purple glove syndrome with phenytoin use
3. Hemolytic anemia from ceftriaxone use
4. Contact dermatitis from neomycin use

____ 13. Drugs that are prone to cause adverse drug effects include:

1. Diuretics
2. Inhaled anticholinergics
3. Insulins
4. Stimulants

____ 14. The U.S. Food and Drug Administration MedWatch system is activated when:

1. There is an adverse event to a vaccine.
2. The patient has a severe reaction that is noted in the “Severe Reaction” section in the medication label.
3. A lactating woman takes a medication that is potentially toxic to the breastfeeding infant.
4. An adverse event or serious problem occurs with a medication that is not already identified on the label.

____ 15. The Vaccine Adverse Events Reporting System is:

1. A mandatory reporting system for all health-care providers when they encounter an adverse vaccine event
2. A voluntary reporting system that health-care providers or consumers may use to report vaccine adverse events
3. Utilized to send out safety alerts regarding emerging vaccine safety issues
4. Activated when a vaccine has been proven to cause significant adverse effects

Chapter 5. Adverse Drug Reactions

Answer Section

MULTIPLE CHOICE

1.ANS:3PTS:1

2.ANS:2PTS:1

3.ANS:4PTS:1

4.ANS:2PTS:1

5.ANS:2PTS:1

6.ANS:4PTS:1

7.ANS:1PTS:1

8.ANS:1PTS:1

9.ANS:2PTS:1

10.ANS:2PTS:1

11.ANS:3PTS:1

12.ANS:1PTS:1

13.ANS:3PTS:1

14.ANS:4PTS:1

15.ANS:2PTS:1

There are no reviews yet.

Add a review

Be the first to review “Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition By Robinson – Test Bank”

Your email address will not be published. Required fields are marked *

Category:
Cart Close
Updating…
  • No products in the cart.

Continue shopping